Methods to prevent, inhibit, or slow the development of vitrectomy-induced cataracts are disclosed. The methods comprise administering to the eye of a subject a composition comprising an ophthalmologically acceptable carrier or diluent and at least one hydroxylamine compound in a therapeutically sufficient amount to prevent, inhibit, or slow the development of a vitrectomy-induced cataract in the subject to which the composition is administered.
This application is a continuation-in-part of U.S. application Ser. No. 10/440,583, filed May 19, 2003, now U.S. Pat. No. 7,442,711 and claims benefit of U.S. Provisional Application No. 60/684,677, filed May 26, 2005. The entire contents of U.S. Provisional Application No. 60/684,677 are incorporated by reference herein.
